Oxidative metabolic products released from polymorphonuclear leukocytes in middle ear fluid during experimental pneumococcal otitis media.
To determine whether oxidative metabolic products of phagocytic cells are present in the middle ear during experimental pneumococcal otitis media, we measured the concentration of myeloperoxidase (MPO) in middle ear fluid (MEF) and the capacity of neutrophils isolated from MEF and peripheral blood to produce MPO and superoxide anion (O2-) after in vitro stimulation. Free MPO in MEF was significantly increased 24 and 48 h after either viable or nonviable pneumococci were inoculated into the middle ear. In vitro-stimulated production of MPO and O2- from middle ear neutrophils was significantly less than that from peripheral blood neutrophils 24 h after nonviable pneumococci were inoculated but similar to it after 48 h. Twenty-four hours after viable pneumococci were inoculated, middle ear neutrophils stimulated in vitro produced less MPO but the same amount of O2- as did blood neutrophils. Oxidative metabolic products, therefore, are released from phagocytic cells into the MEF during pneumococcal otitis media, and future studies will need to define the contribution of these products to acute and chronic middle ear tissue injury.
Kawana
M
M
Otitis Media Research Center, University of Minnesota, School of Medicine, Minneapolis 55455.
Kawana
C
C
Yokoo
T
T
Quie
P G
PG
Giebink
G S
GS
D000818:Animals; D015550:Cell Degranulation; D002682:Chinchilla; D009504:Neutrophils / Q000378:metabolism*; D010033:Otitis Media / Q000382:microbiology / Q000503:physiopathology*; D009195:Peroxidase / Q000378:metabolism; D011008:Pneumococcal Infections / Q000382:microbiology / Q000503:physiopathology*; D013296:Streptococcus pneumoniae / Q000472:pathogenicity*; D013481:Superoxides / Q000378:metabolism; D013997:Time Factors
D013481:Superoxides; D009195:Peroxidase